Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.
复制标题
用 PARC 相互作用肽处理的肿瘤细胞中 p53 依赖性反应的激活。
DOI:
10.1016/j.bbrc.2008.01.093
复制
发表时间:
2008
影响因子:
3.1
通讯作者:
Raschellà,Giuseppe
中科院分区:
文献类型:
--
作者:
Vitali,Roberta;Cesi,Vincenzo;Tanno,Barbara;Ferrari-Amorotti,Giovanna;Dominici,Carlo;Calabretta,Bruno;Raschellà,Giuseppe
We tested the activity of a p53 carboxy-terminal peptide containing the PARC-interacting region in cancer cells with wild type cytoplasmic p53. Peptide delivery was achieved by fusing it to the TAT transduction domain (TAT-p53-C-ter peptide). In a two-hybrid assay, the tetramerization domain (TD) of p53 was necessary and sufficient to bind PARC. The TAT-p53-C-ter peptide disrupted the PARC–p53 complex. Peptide treatment caused p53 nuclear relocation, p53-dependent changes in gene expression and enhancement of etoposide-induced apoptosis. These studies suggest that PARC-interacting peptides are promising candidates for the enhancement of p53-dependent apoptosis in tumors with wt cytoplasmic p53.